Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

Minimal residual disease (MRD) assays allow response assessment in patients with multiple myeloma (MM), and negativity is associated with improved survival outcomes. The role of highly sensitive next generation sequencing (NGS) MRD in combination with functional imaging remains to be validated. We p...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonseca, Rodrigo, Arribas, Mariano, Wiedmeier-Nutor, Julia E., Kusne, Yael N., González Vélez, Miguel, Kosiorek, Heidi E., Butterfield, Richard (Duke) J., Kirsch, Ilan R., Mikhael, Joseph R., Stewart, A. Keith, Reeder, Craig, Larsen, Jeremy, Bergsagel, P. Leif, Fonseca, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988896/
https://www.ncbi.nlm.nih.gov/pubmed/36878906
http://dx.doi.org/10.1038/s41408-023-00794-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988896/
https://www.ncbi.nlm.nih.gov/pubmed/36878906
http://dx.doi.org/10.1038/s41408-023-00794-x

Ejemplares similares